Galvanize Therapeutics: Funding, Investors & Team (Oct 2026)
Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. It was formed by Apple Tree Partners in 2022.
Galvanize Therapeutics has raised $100M across 1 funding round on record, the most recent a Series B of $100M announced in Sep 2022.
That round is above the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.
Galvanize Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Galvanize Therapeutics Funding Rounds
Galvanize Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Galvanize Therapeutics Funding Compared to Other Health Care Startups
Galvanize Therapeutics' latest round of $100M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Galvanize Therapeutics in Health Care and San Carlos
Companies Similar to Galvanize Therapeutics
Treso operates as a financial software provider that develops an integrated financial operating system…
Optain produces medical tools and technology with the aim of providing healthcare access to everyone,…
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Galvanize Therapeutics Funding FAQs
What does Galvanize Therapeutics do?
Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. It was formed by Apple Tree Partners in 2022.
How much funding has Galvanize Therapeutics raised?
Galvanize Therapeutics has raised $100M across 1 round on record. The most recent is a Series B of $100M announced in Sep 2022.
When did Galvanize Therapeutics last raise funding?
Galvanize Therapeutics' most recent funding round on record is a Series B of $100M, announced in Sep 2022.
Who is the CEO of Galvanize Therapeutics?
Jonathan Waldstreicher is listed as CEO at Galvanize Therapeutics.
Where is Galvanize Therapeutics headquartered?
Galvanize Therapeutics is based in San Carlos, California, United States.
How many employees does Galvanize Therapeutics have?
Galvanize Therapeutics is in the 51-100 employee band.
How does Galvanize Therapeutics' funding compare to other Health Care startups?
Galvanize Therapeutics' latest round of $100M is above the $5.0M median round size for Health Care companies on FundedIQ across 3,660 tracked companies over the last two years.
About FundedIQ's Galvanize Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Galvanize Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.